PeptiDream uses PDPS tech to discover new drug projects for Sanofi
PeptiDream Inc. agreed to use its Peptide Discovery Platform System (PDPS) macrocyclic/constrained peptide generation platform against multiple undisclosed targets selected by Sanofi.
- Drug Discovery Technologies
- Large Molecule
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.